Theme · live manifest · live theme JSON
Biotech '25: Oncology & Immunotherapy
12 tickers (manifest)
Group: Biotech
Biotech '25: Oncology & Immunotherapy tracks 12 publicly listed stocks in this theme: ACLX, AVBP, CGEM, CRSP, JANX, NRIX, NUVB, NUVL, PTGX, RIGL, RVMD, ZYME. See the constituent table for details.
Constituents
Data as of · build 20260331T211629
| Ticker | Name | Market cap | Weight |
|---|---|---|---|
ACLX | Arcellx, Inc. | $6.71B | 8.3333 |
AVBP | ArriVent BioPharma, Inc. Common Stock | $928.7M | 8.3333 |
CGEM | Cullinan Therapeutics, Inc. | $812.3M | 8.3333 |
CRSP | CRISPR Therapeutics AG | $4.26B | 8.3333 |
JANX | Janux Therapeutics, Inc. | $792.6M | 8.3333 |
NRIX | Nurix Therapeutics, Inc. | $1.27B | 8.3333 |
NUVB | Nuvation Bio Inc. | $1.40B | 8.3333 |
NUVL | Nuvalent, Inc. | $7.08B | 8.3333 |
PTGX | Protagonist Therapeutics, Inc. | $6.37B | 8.3333 |
RIGL | Rigel Pharmaceuticals, Inc. | $475.1M | 8.3333 |
RVMD | Revolution Medicines, Inc. | $18.37B | 8.3333 |
ZYME | Zymeworks Inc. | $1.80B | 8.3333 |